Details about Joseph DiMasi

Access statistics for papers by Joseph DiMasi.

Last updated 2016-05-25. Update your information in the RePEc Author Service.

Short-id: pdi386

Working Papers

2003

1. Returns on R&D for 1990s New Drug Introductions
   Levine's Working Paper Archive, David K. Levine
   Also in Working Papers, Duke University, Department of Economics (2002) View citations (2)
2. Returns on R&D for 1990s New Drug Introductions: Charts
   Levine's Working Paper Archive, David K. Levine

1995

3. R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry
   Working Papers, Duke University, Department of Economics View citations (21)
   See also Journal Article R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry, International Journal of the Economics of Business, Taylor & Francis Journals (1995) View citations (21) (1995)

Journal Articles

2016

1. Innovation in the pharmaceutical industry: New estimates of R&D costs
   Journal of Health Economics, 2016, 47, (C), 20-33 View citations (158)

2010

2. Drug development costs when financial risk is measured using the Fama–French three‐factor model
   Health Economics, 2010, 19, (8), 1002-1005 View citations (10)

2007

3. Commentary
   Managerial and Decision Economics, 2007, 28, (4-5), 285-291
4. The cost of biopharmaceutical R&D: is biotech different?
   Managerial and Decision Economics, 2007, 28, (4-5), 469-479 View citations (26)

2005

5. Extraordinary claims require extraordinary evidence
   Journal of Health Economics, 2005, 24, (5), 1034-1044 View citations (6)
6. Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinder
   Journal of Health Economics, 2005, 24, (5), 1049-1053 View citations (4)
7. The economics of follow-on drug research and development: Trends in entry rates and the timing of development — The authors’ reply
   PharmacoEconomics, 2005, 23, (12), 1193-1202 View citations (1)

2003

8. The price of innovation: new estimates of drug development costs
   Journal of Health Economics, 2003, 22, (2), 151-185 View citations (365)

1995

9. R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry
   International Journal of the Economics of Business, 1995, 2, (2), 201-219 View citations (21)
   See also Working Paper R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry, Working Papers (1995) View citations (21) (1995)

1991

10. Cost of innovation in the pharmaceutical industry
    Journal of Health Economics, 1991, 10, (2), 107-142 View citations (124)

1988

11. Property tax classification and welfare in urban areas: A general equilibrium computational approach
    Journal of Urban Economics, 1988, 23, (2), 131-149 View citations (1)